We also observed that NF-kB, mitogen-activated protein kinase (MAPK), and protein kinase B (PKB, known as AKT) pathways involved in BTZ resistance were inactivated by HDAC6-selective inhibitor in both BTZ-sensitive and BTZ-resistant MM cells. This evidence concerns the gene AKT1 and Miyoshi myopathy.